Lilly Together™ is designed to help you as a Taltz® (ixekizumab), Olumiant® (baricitinib), EBGLYSS™ (lebrikizumab-lbkz), or Omvoh™ (mirikizumab-mrkz) user to manage your condition.
Please see Indications and Safety Summary including WARNINGS for Olumiant® (baricitinib) at https://www.olumiant.com/?section=isi
When you download and use the Lilly Together™ mobile app, features will be customized based on your treatment plan and condition and may include:
· Plan Setup: Set up your dosing plan, schedule dosing reminders, and track when to take your medication.
· Treatment Map: View your treatment map for a summary of what to expect during your first 6 months of treatment, including treatment touchpoints, recommended dosing, and symptom tracking.
· Dose/Medication Tracking: Log your injections or infusions to view if you are staying on track and taking your medication as your Healthcare Provider prescribed.
· Symptom Tracking: Track and monitor your symptoms over time. You can take photos that will not appear in your camera roll to keep all your symptom information in one location.
· Progress: The app puts you in control of tracking your progress, which may help you to have better conversations with your Healthcare provider.
· Logbook Report: Download a logbook report for a 90-day view of your symptom and dosing trends. This may help you understand the progress you're making on treatment so you can share the information with your Healthcare Provider.
· Additional Features: The app also offers Savings Card enrollment for eligible commercially insured patients, the ability to request a free FDA-cleared Sharps Disposal container, helpful resources, and one-click-away customer support.
Note: This app is intended for the exclusive use of U.S. residents 18 years of age and older. Lilly Together™ is not intended to provide diagnostic and/or treatment decisions or replace the care and advice of a licensed Healthcare Provider. All medical analysis and treatment plans should be performed by a licensed Healthcare Provider.
Still have questions?
You can call for additional support at 1-844-486-8546.
Lilly Together™ is a trademark owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.
Taltz® and its delivery device base are trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.
Olumiant® is a registered trademark owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.
Omvoh™ and its delivery device base are trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.
EBGLYSS™, its delivery device base, Lilly Support Services™, and Companion in Care™ are trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates
PP-LU-US-0732
Show less
What's New in Lilly Together™
15.0.0
November 25, 2024
The latest version contains:
• Medication and tracking support for EBGLYSS™ (lebrikizumab-lbkz):
o Access information about your medication and possible savings
o Log your injections and view plan for upcoming doses
o Log and monitor your symptoms over time in the logbook
o Access a treatment map that allows you to see key steps in your treatment journey
o Create a logbook report that you can save and share outside of the app with your Healthcare Provider
• Medication Ready Timer: Taltz® (ixekizumab), and Omvoh™ (mirikizumab-mrkz) users can use this feature to count down the time you should leave your medication at room temperature before injecting. You will be prompted to start the timer on your dosing days, although its use is optional.
I was just approved for Taltz, and getting ready to do my first injection. Previously used AbbVie’s app for Humira and never had an issue with the 2+ years I used it. This app won’t even let me log in. It says it sent a verification email, and nothing. Checked all the folders and mailboxes. Nothing. The app says I can proceed without doing the verification. But I can’t. It takes me back to the log in page. Vicious circle. I hate this medication already because of the lack of support via this useless app.
Show less
Response from developer
We’re sorry you are having trouble signing up. First, check your spam or junk folders for the email. You can search for noreply@mc-q.lilly.com as the sender. If you still can't find it, then you may have mis-typed your email address when you signed up. If you think that this happened, then please delete and re-install the app. Then sign up again, making sure to confirm your email address is entered correctly.
If this doesn’t work, please call us at 1-844-486-8546, Monday through Friday, between 8AM - 10PM EST.
